Skip Navigation
Search Menu
News and Publications

In This Section      
Print This Page

Inside Tract - On Why Academic Medical Centers Must Thrive

Inside Tract Spring 2013

On Why Academic Medical Centers Must Thrive

By: Anthony N. Kalloo, M.D.
Date: July 5, 2013

If you ever needed reasons why academic medical centers need to be kept strong and impervious to the winds of sequesters, Medicare caps and NIH cutbacks, they’re in this issue of Inside Tract. 

Our clinician-scientists offered the know-how in designing and running clinical trials that helped bring a breakthrough—we don’t use that word lightly—in therapy for hepatitis C. As you read this, they’re considering how to adapt the bounty of more effective drugs for all of our patients, in every stage of the disease that’s receptive.

Esteban Mezey’s decade of research on fat-soluble vitamins fits into his new molecular findings to suggest that tapping a natural brake on liver cirrhosis is possible and worth large-scale testing. Xuhang Li’s lab is on its way to useful biomarkers that not only point out a patient’s subtype of inflammatory bowel disease but also report who risks serious complications.  

And even though we weren’t on the discovery end of newer, patient-friendly tactics for fecal incontinence, our clinicians have been quick to make them their own and alert patients who’d otherwise suffer.

We invite you to call on us to learn how we can contribute to your practice.


Anthony N. Kalloo, M.D.
Johns Hopkins Division of

Gastroenterology and Hepatology

Related Content